Crossmark

Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway

Crossref DOI link: https://doi.org/10.1186/s13046-018-1015-9

Published Online: 2019-01-23

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Lehe

Lin, Shichong

Kang, Yanting

Xiang, Youqun

Xu, Lingyuan

Li, Jifa

Dai, Xuanxuan

Liang, Guang

Huang, Xiaoying

Zhao, Chengguang
Funding

Funding for this research was provided by:

National Key R&D Program of China (2017YFA0506000)

National Natural Science Funding of China (81622043)

Medical Scientific Research Fund of Zhejiang Province (2019322308)

Zhejiang Provincial Natural Science Foundation of China (LR16H310001, LY18H160047, LY17H160055)

Wenzhou science and technology project (Y20170280)
License Information

Text and Data Mining valid from 2019-01-23
More Information

Article History

Received: 17 April 2018

Accepted: 19 December 2018

First Online: 23 January 2019

Ethics approval

: All animal studies were performed with an approved protocol by the Institutional Animal Care and Use Committee of Wenzhou Medical University.

: The authors declare that they agree to submit the article for publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.